Biotech

CytRx Corporation (NASDAQ:CYTR) shares were down 15.02% on Thursday to $0.685 and an additional 7.65% in after-hours trading to $0.632. The company has a market cap of $75.70 million at 117.32 million shares outstanding. Share prices have been trading in a 52-week range of $0.36 to $3.46. CytRx Corporation is a...

When some of the biggest names in the biotechnology space all turn their attention towards one company at once, and especially when that company is a relatively under the radar stock, it's worth taking notice. This is exactly what's happened with VBI Vaccines, Inc. - Ordinary Shares (NASDAQ:VBIV). A list...

The history of modern healthcare is littered with advances that stand out from others as changing the course of the space. The transition from naturally sourced to recombinant DNA produced insulin. The introduction of pacemakers and stents in the cardiac sector. Going back a little further, the introduction of...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Vbi Vaccines Inc. (NASDAQ:VBIV) reported that Opko Health, Inc. has picked up 6,023,014 of common stock as of 2017-03-31. The acquisition brings the aggregate amount owned by Opko Health, Inc. to a total of 6,023,014...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cas Medical Systems Inc. (NASDAQ:CASM) reported that Patton Thomas M has picked up 1,623,389 of common stock as of 2017-04-04. The acquisition brings the aggregate amount owned by Patton Thomas M to a total of...